Isotonitazene has been identified in eight blood specimens associated with postmortem death investigations in the United States since August 2019. Isotonitazene was first reported in August 2019 based on the results from seized drug and toxicology casework in Europe (Belgium) and Canada (Alberta); the Canadian toxicology case was collected in March 2019.
(Publisher abstract provided.)
Similar Publications
- “Nothing I said would have mattered”: Categorizing barriers to intervening in workplace mistreatment
- Criminal Justice Interventions for Offenders With Mental Illness: Evaluation of Mental Health Courts in Bronx and Brooklyn, New York, Executive Summary
- Media Contact and Posttraumatic Stress in Employees of New York City Area Businesses after the September 11 Attacks